With the popularity of hemodialysis treatment, the selection of hemodialysis concentrate has gradually become a focus of attention for patients and medical institutions. Choosing the appropriate dialysis concentrate can not only effectively remove metabolic waste, but also reduce the risk of adverse reactions.

In recent years, the global hemodialysis market has continued to expand, mainly driven by the increasing prevalence of chronic kidney disease and the aging trend.

In February 2024, Hebei Ziweishan Pharmaceutical Co., Ltd. was rated as an "Excellent Private Enterprise" by the Baoding Municipal Party Committee and Municipal Government. This is a sign of the company's success in hemodialysis Highly recognized for contributions to the product and medical device fields.